title: Repeated cationic multilamellar liposome-mediated gene transfer enhanced transduction efficiency against murine melanoma cell lines.
abstract: We investigated whether repeated cationic multilamellar liposome-mediated gene transfers enhanced the transduction efficiency against murine melanoma cell lines and experimental subcutaneous melanoma. In the former, the murine melanoma cell line, B16F10, was transfected by our original cationic multilamellar liposomes containing pVLacZ, which express beta-galactosidase in eukaryotic cells. Cells were exposed to the liposomes in a single, double, or triple procedure during the cell logarithmic proliferative period. We then evaluated the transduction efficiency by X-gal staining and beta-galactosidase assay. The number of positive cells and level of beta-galactosidase activity were significantly increased by repeated exposures compared with a single one. Cells transfected by the fluorescently labeled cationic liposome containing pEGFP-C1 showed both an increased uptake of liposomes and an increased number of EGFP expression cells following repeated exposures. In the latter, murine subcutaneous melanomas, which were made by transplantation of B16F10 in C57BL6 mice, were transfected by same liposomes. Subcutaneous melanomas were exposed to the liposomes in a single, double, or triple procedure. We then evaluated the transduction efficiency by the beta-galactosidase assay. The level of beta-galactosidase activity was significantly increased by repeated exposures compared with a single one. The results indicate that repeated exposures to the liposomes enhanced the transduction efficiency toward murine melanoma cells and experimental subcutaneous melanoma, and may provide a basis for the repeated-exposure protocol for human trials.
authors.affiliation: Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Japan.
authors.forename: Misato
authors.initials: M
authors.lastname: Nobayashi
authors.forename: Masaaki
authors.initials: M
authors.lastname: Mizuno
authors.forename: Toshiro
authors.initials: T
authors.lastname: Kageshita
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Saida
authors.forename: Jun
authors.initials: J
authors.lastname: Yoshida
mesh_terms: D000818:Animals; D002412:Cations; D002470:Cell Survival / Q000187:drug effects; D018014:Gene Transfer Techniques / Q000592:standards*; D007279:Injections, Subcutaneous; D008081:Liposomes / Q000008:administration & dosage / Q000009:adverse effects / Q000506:poisoning; D008545:Melanoma / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D008546:Melanoma, Experimental / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D012878:Skin Neoplasms / Q000503:physiopathology; D018675:Toxicity Tests; D014407:Tumor Cells, Cultured
chemical_list: D002412:Cations; D008081:Liposomes